Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Pegteograstim on Chemotherapy-induced Neutropenia in Children With Solid Tumors

NCT02787876 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02787876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02787876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Pegteograstim on Chemotherapy-induced Neutropenia in Children With Solid Tumors
Lead sponsor
Samsung Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
October 4, 2016
Completion date
November 30, 2018
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced neutropenia, pediatric solid tumor